Biodesix, Inc.
NASDAQBDSX reports Q1 2026 results on May 8 with the stock carrying a 25% monthly loss into the print — yet showing signs of near-term stabilisation. The price action tells a split story. Shares fell sharply through April to close at $11.27, but clawed back more than 11% over the past week and added 1.7% on Monday. That recovery narrows the gap to the analyst consensus price target of…
Snapshot as of 7 May 2026
BDSX reports Q1 2026 results on May 8 with the stock carrying a 25% monthly loss into the print — yet showing signs of near-term stabilisation. The price action tells a split story. Shares fell sharply through April to…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for BDSX — free to start on ORTEX.
Sign up for free →Open BDSX on ORTEX